Page 138 - 20211214_OHKF_Health_Finance_Research_Report_E (1)
P. 138

Some interviewees worried that the design of a chronic disease screening voucher and
            scheme for subsequent management might be disease-centred and contradict the
            health-centred model in the desired primary care-led system. Stakeholders suggested
            that the Government should carefully define the services to be covered by
            the vouchers to ensure that they are used in preventive services rather than solely
            disease treatment.


                  Stakeholders’ voices




          The difficulty of issuing a chronic disease voucher is the definition of
          chronic disease. And the overall problem, as you have mentioned in the
          report (OHKF, 2018), is about services being segmented, fragmented,
          too disease-oriented, and so forth… If you (the Government) focus on
          chronic disease assessment, screening, early identification, it might also
          be disease-oriented instead of health-oriented.

          Academic





                                          You (patients) can have impaired function without
                                          diseases, and this is still going to make you disabled,
                                          right? You (the Government) could detect these things
                                          before they become disabled... You can’t just target
                                          NCDs (non-communicable diseases)… You have to
                                          target both (NCDs and geriatric syndromes).
                                          Academic





          The goal is to shift the start of care from the time when they
          are already sick to when they are still healthy; to shift the
          whole timeframe earlier.
          Private service provider











            Regarding the scope of the Scheme, there were diverse opinions among stakeholders. Some
            agreed with the HDH (hypertension-diabetes-hyperlipidaemia) approach, citing
            its high prevalence in Hong Kong, while others suggested expanding the diagnostic tests to
            uric acid, osteoporosis, and other health indicators, such as obesity. A few insisted on the
            need to include Body Mass Index (BMI) measurements in the Scheme, which they regarded
            to be a highly important indicator for risk factor for chronic diseases. However, stakeholders
            who supported the HDH approach were also opposed to the expansion of the screening
            scope due to feasibility concerns.








       136
   133   134   135   136   137   138   139   140   141   142   143